Finstal-5

Overview

Finstal-5 contains finasteride, a medication used to treat benign prostatic hyperplasia (BPH) and male pattern baldness. It belongs to a class of medications called 5-alpha reductase inhibitors, which work by preventing the conversion of testosterone to dihydrotestosterone (DHT), a hormone linked to prostate growth and hair loss.

Benefits

• Benign Prostatic Hyperplasia (BPH): Helps shrink an enlarged prostate, improving urinary symptoms such as difficulty in urination, weak stream, and frequent urge to urinate.
• Male Pattern Baldness: Promotes hair regrowth and prevents further hair loss in men by reducing scalp DHT levels.

How to Use

• Dosage: The usual dose for BPH is one 5 mg tablet once daily. For male pattern baldness, the dose is typically one 1 mg tablet daily.
• Administration: Can be taken with or without food. Swallow the tablet whole with water.

Precautions

• Pregnancy and Breastfeeding: Not intended for use by women. Pregnant women should not handle crushed or broken tablets due to the risk of birth defects.
• Liver Disease: Use with caution if you have liver issues. Regular liver function tests may be necessary.
• Allergic Reactions: Avoid use if allergic to finasteride. Seek immediate medical attention if you experience symptoms like rash, itching, swelling, severe dizziness, or difficulty breathing.

Side Effects

Common side effects include:

• Decreased sexual desire
• Erectile dysfunction
• Decreased semen volume
• Breast tenderness or enlargement
• Rash

Serious side effects requiring medical attention include:

• Breast pain or lumps
• Nipple discharge
• Testicular pain
• Depression or mood changes

Storage

• Store at room temperature away from moisture, heat, and light.
• Keep out of reach of children.

Finstal-5 provides an effective treatment for managing symptoms of BPH and male pattern baldness, contributing to improved quality of life and overall well-being. Always follow your healthcare provider's instructions and report any persistent or severe side effects.